Figure 4From: Complete response for advanced liver cancer during sorafenib therapy: Case Report Twelve-months follow up with MRI before and after after injection of Primovist: 5a, T1-weighted; 5b, T2-weighted:On baseline T1w.i and T2w.i no sign of changes of signal intensity within the liver parenchyma is appreciable, not even at the level of the previous lesion of segment III.Back to article page